Method for treating fibromyalgia
AssigneesNagasaki University, MSS, Inc.
InventorHiroshi Ueda
Life of this patent
Estimating the term…
Abstract
Provided is a therapeutic or prophylactic agent for generalized pain syndrome, for which no cause and therapies have been established. A therapeutic or prophylactic agent for generalized pain syndrome containing an LPA1 antagonist or autotaxin-inhibiting substance as an active ingredient. The pharmaceutical is preferably administered to the central nervous system. The generalized pain syndrome is preferably fibromyalgia, chronic fatigue syndrome or hypersensitivity colitis.
Claims1
A method of treating fibromyalgia in a subject comprising administering to the subject an effective amount of a low-molecular weight compound that binds to LPA1 to inhibit signaling, thereby treating fibromyalgia in the subject.
Dependencies are inferred from the claim text.